Browse the latest research summaries in the field of urology for spinal cord injury patients and caregivers.
Showing 191-200 of 389 results
CUAJ, 2014 • November 24, 2014
This retrospective cohort study examined urologic care patterns among TSCI patients in Ontario between 2002 and 2012. It found that a significant proportion of patients do not receive urologic assessm...
KEY FINDING: Only 66% of TSCI patients were assessed by a urologist, with a median time of 0.7 years after the injury.
PLoS ONE, 2014 • December 29, 2014
The primary outcome was the between-group difference in the change of total NIH-CPSI score from baseline to 12 weeks. The observed difference of 3 points corresponds to an effect size of 0.5 to 0.6 st...
KEY FINDING: Sono-electro-magnetic therapy did not result in a significant improvement of symptoms in the overall cohort of treatment refractory CPPS patients compared to placebo treatment.
PLoS ONE, 2016 • August 30, 2016
This study compares heart rate variability (HRV) and systolic blood pressure (SBP) changes of spinal cord injury (SCI) patients during urodynamic study (UDS) with able-bodied controls. Tetraplegic pat...
KEY FINDING: Only control subjects displayed significant elevation of SBP during Foley catheter insertion compared to resting values.
Ann Rehabil Med, 2016 • August 26, 2016
This retrospective study investigated risk factors for urinary tract infection (UTI) following urodynamic study (UDS) in 140 spinal cord injury (SCI) patients receiving prophylactic antibiotics. The k...
KEY FINDING: A history of UTI within the past 4 weeks prior to the UDS was significantly associated with UTI occurrence after the UDS, even with prophylactic antibiotic therapy (p=0.006).
The Journal of Spinal Cord Medicine, 2015 • April 1, 2015
This review discusses neurogenic lower urinary tract dysfunction (NLUTD) following spinal cord injury and the development of electrical stimulation as an approach to restore bladder function, includin...
KEY FINDING: Electrical stimulation techniques, including pudendal nerve stimulation and high-frequency nerve block, show promise in controlling bladder function.
The Journal of Spinal Cord Medicine, 2015 • January 1, 2015
The Academy of Spinal Cord Injury Professionals (ASCIP) is seeking new leadership for the Journal of Spinal Cord Medicine (JSCM). An article emphasizes the significance of urodynamic studies in SCI pa...
KEY FINDING: Urodynamic studies are crucial for precise neurological assessment in determining appropriate bladder management for patients with SCI.
Brazilian Journal of Infectious Diseases, 2016 • October 18, 2016
This retrospective study evaluated the effectiveness of different antibiotic protocols in preventing urinary tract infections (UTIs) in patients with neurogenic bladder undergoing botulinum toxin A (B...
KEY FINDING: The study found a low overall rate of symptomatic UTIs (1.8%) among patients receiving botulinum toxin A injections for neurogenic bladder.
Research and Reports in Urology, 2013 • October 9, 2013
The study aimed to develop a patient-reported neurogenic bladder symptom score (NBSS) to quantify urinary symptoms and complications in patients with neurogenic bladder dysfunction. The development pr...
KEY FINDING: The study identified eight quality of life measures and 29 symptom-specific instruments related to neurogenic bladder.
The Journal of Spinal Cord Medicine, 2016 • May 1, 2016
The case reports highlight a rare complication of long-term indwelling catheter use in SCI patients, specifically penile cleavage. Contributing factors include poor catheter care, underlying medical c...
KEY FINDING: Penile cleavage is a rare but significant complication of long-term indwelling catheter use in SCI patients with neurogenic bladder.
Spinal Cord, 2016 • August 11, 2015
This study evaluated the effectiveness and safety of combined detrusor-trigone BTX-A injections for treating urinary incontinence secondary to neurogenic detrusor overactivity (NDO) in spinal cord inj...
KEY FINDING: BTX-A injections into both the detrusor and trigone muscles resulted in significantly better improvements in I-QoL compared to detrusor-only injections at 12 weeks post-injection.